102 related articles for article (PubMed ID: 3882231)
1. Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma.
Tannock IF; Evans WK
Cancer Treat Rep; 1985 Feb; 69(2):227-8. PubMed ID: 3882231
[No Abstract] [Full Text] [Related]
2. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.
Kuebler JP; Hogan TF; Trump DL; Bryan GT
Cancer Treat Rep; 1984 Jun; 68(6):925-6. PubMed ID: 6733709
[No Abstract] [Full Text] [Related]
4. [Progression of late metastases of renal cell carcinoma].
Wittekind C
Dtsch Med Wochenschr; 2006 Apr; 131(17):994. PubMed ID: 16673224
[No Abstract] [Full Text] [Related]
5. [A case of lung metastasis from renal cell carcinoma showing complete response by a combination chemotherapy with methotrexate, vinblastine and pepleomycin (MVP)].
Tamaki M; Maeda S; Iwata H; Yamamoto N; Kuriyama M; Ban Y; Kawada Y
Hinyokika Kiyo; 1995 Mar; 41(3):205-7. PubMed ID: 7741073
[TBL] [Abstract][Full Text] [Related]
6. An update on a case of regression of lung metastases after radiotherapy for bone metastasis in renal cell carcinoma.
Jafri M; Protheroe A
Clin Oncol (R Coll Radiol); 2008 May; 20(4):316. PubMed ID: 18329259
[No Abstract] [Full Text] [Related]
7. [Chemotherapy of renal cell carcinoma. 2. Combined chemotherapy using ACNU and VBL].
Kobayashi M; Imai K; Nakai K; Kumasaka F; Suzuki T; Ito Y; Yamanaka H; Sugihara S
Hinyokika Kiyo; 1986 Mar; 32(3):375-83. PubMed ID: 3460318
[TBL] [Abstract][Full Text] [Related]
8. [Radiotherapy in treatment of relapsing renal cell cancer].
Metelev VV; Zharinov GM
Vopr Onkol; 2008; 54(6):775-7. PubMed ID: 19241859
[No Abstract] [Full Text] [Related]
9. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Kijima T; Fujii Y; Suyama T; Okubo Y; Yonese J; Fukui I
Int J Urol; 2008 Jun; 15(6):546-7. PubMed ID: 18489646
[TBL] [Abstract][Full Text] [Related]
10. [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].
Kakehi Y; Hashimura T; Yoshida O; Segawa T; Kanematsu A
Hinyokika Kiyo; 1993 Dec; 39(12):1227-32. PubMed ID: 8285174
[TBL] [Abstract][Full Text] [Related]
11. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
12. [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].
Kakehi Y; Yoshida O; Segawa T; Kanematsu A; Hiura M; Shichiri Y; Arai Y
Hinyokika Kiyo; 1994 Oct; 40(10):925-9. PubMed ID: 7992710
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of renal cell carcinoma. 3. Single-agent therapy with FT-207 or vinblastine].
Satomi Y; Senga Y; Fukuda M; Nakahashi M; Ohshima H; Furuhata A
Nihon Hinyokika Gakkai Zasshi; 1984 Jun; 75(6):903-8. PubMed ID: 6438382
[No Abstract] [Full Text] [Related]
14. Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000.
Gez E; Rubinov R; Gaitini D; Meretyk S; Best LA; Native O; Stein A; Erlich N; Beny A; Zidan J; Haim N; Kuten A
Cancer; 2002 Oct; 95(8):1644-9. PubMed ID: 12365011
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma.
Shah MK; St Marie K; Catalano RB; Dierks K; Creech RH
Cancer Treat Rep; 1985 Feb; 69(2):229-30. PubMed ID: 3882232
[No Abstract] [Full Text] [Related]
17. [Evaluation of bone metastases from renal cell carcinoma].
Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
[TBL] [Abstract][Full Text] [Related]
18. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
Haas NB; Giantonio BJ; Litwin S; Minniti CJ; Fox S; Yeslow G; Reilly R; Nahum K; Greenberg R; Halbherr T; Hudes GR
Cancer; 2003 Nov; 98(9):1837-41. PubMed ID: 14584064
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
Procopio G; Verzoni E; Gevorgyan A; Mancin M; Pusceddu S; Catena L; Platania M; Guadalupi V; Martinetti A; Bajetta E
Oncology; 2007; 73(3-4):204-9. PubMed ID: 18418013
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of surgical treatment for bone metastatic lesion in renal cell carcinoma].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Nakamura T; Watanabe H
Hinyokika Kiyo; 1995 Apr; 41(4):241-4. PubMed ID: 7785552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
